Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Authors´reply

Схожі ресурси

• Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Authors´reply
  за авторством: Seyer Safi, та інші
  Опубліковано: (2025-12-01)
• Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading
  за авторством: Moritz Jesinghaus, та інші
  Опубліковано: (2022-11-01)
• Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
  за авторством: Xiaoyu Zhai, та інші
  Опубліковано: (2017-05-01)
• Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer
  за авторством: Seyer Safi, та інші
  Опубліковано: (2019-12-01)
• Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
  за авторством: Seiichiro Kusuhara, та інші
  Опубліковано: (2021-05-01)